Corcept Therapeutics
Oncology Therapeutics · Cardiometabolic Therapeutics
22open roles
$220kmedian advertised pay
Scaling fasthiring pace, 77 of 100
4countries with offices
Overview
Headquartered in Redwood City, California, Corcept Therapeutics is a commercial-stage biopharmaceutical company focused on cortisol modulation. The organization specializes in the discovery, development, and commercialization of medications to treat serious endocrine, metabolic, oncologic, and neurologic disorders. Its clinical pipeline and commercial portfolio include targeted treatments for conditions such as Cushing's syndrome and various cancers.
Jobs
$185k – $240k per year · Hybrid · Full-Time · 8+ years exp · Redwood City
Prometheus
AWS
Cortex
Cybersecurity
Okta
Crowdstrike
NIST CSF
Apply
$185k – $240k per year · Hybrid · Full-Time · 8+ years exp · Bachelor's Degree · Redwood City
SAS
Terraform
CloudFormation
AWS
Amazon EC2
Amazon S3
IAM
Amazon CloudWatch
DNS
Cybersecurity
Active Directory
Apply
$160k – $220k per year · Remote (United States) · Full-Time · 2+ years exp · PhD · San Antonio · Washington
SharePoint
Life Sciences
Veeva
Apply
$160k – $220k per year · Remote (United States) · Full-Time · 2+ years exp · PhD · Los Angeles · Washington
SharePoint
Life Sciences
Veeva
Apply
$84k – $99k per year · Hybrid · Full-Time · 1+ year exp · Bachelor's Degree · Redwood City
Apply
$215k – $253k per year · Hybrid · Full-Time · 7+ years exp · Bachelor's Degree · Redwood City
Apply
$173k – $227k per year · In office · Full-Time · 7+ years exp · Bachelor's Degree · Redwood City
GMP
MedTech
CAPA
Apply
$238k – $316k per year · In office · Full-Time · 14+ years exp · Redwood City
Apply
$157k – $184k per year · In office · Full-Time · PhD · Redwood City
GraphPad Prism
Apply
$184k – $270k per year · In office · Full-Time · 4+ years exp · Master's Degree · Redwood City
Apply
$261k – $308k per year · Hybrid · Full-Time · 10+ years exp · PhD · Redwood City
GraphPad Prism
Apply
$340k – $375k per year · Hybrid · Full-Time · 5+ years exp · PhD · Redwood City
Apply
Salary insights
Compensation ranges based on this company's open jobs
Median
$220k
Typical range
$87k – $375k
Open positions
39
38
Jobs
Junior
13.2%
Middle
5.3%
Senior
47.4%
Staff
7.9%
Architect
26.3%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Junior | 5 | $220k | $87k – $220k |
| Middle | 2 | $122k | $119k – $125k |
| Senior | 18 | $189k | $137k – $351k |
| Staff | 3 | $316k | $316k – $351k |
| Architect | 10 | $248k | $223k – $375k |
Highest paying role
Vice President, Biology
$375k
Normalized to USD per year
All salaries at Corcept Therapeutics
By role, level and city, against the market · 39 jobs with pay
Visa sponsorship
4 ▼ 43%
H-1B filings in 12 months
2
Green card filings
$198k
Median offered salary
Who they sponsor
Other managers
1
Statisticians
1
Industrial production managers
1
In the register as CORCEPT THERAPEUTICS, INC., Redwood City, CA (+3 more)
Other sponsors in the same field
Eli Lilly and Company 420 filings
Bristol Myers Squibb 218 filings
Novartis 8 filings
Amgen 372 filings
See 39 open roles Alert me
US Department of Labor · latest filing Mar 28, 2026 · Visa details by country
A-rated
Sponsor licence
Skilled Worker
Visa route
0
Open roles in United Kingdom
In the register as Corcept Therapeutics UK Ltd, London
Other sponsors in the same field
AstraZeneca 
AbbVie 
GSK
Alert me
UK Home Office · checked Nov 8, 2026 · Visa details by country
Growth
Hiring Momentum
77/100
Scaling fast
Open positions
40
12 opened / 29 closed in 30 days
Median time-to-fill
84 days
faster than 14% of the market
ATS activity
Every ~4 hours
Today
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Biotech
28%
Hardware
27% ▼
Sales
15% ▼
HR
8% ▲
Finance
5% ▲
Operations
3% ▼
Actively hiring for Hardware (+3 in 30 days)
Activity Timeline
New location: San Antonio
Nov 2026
New location: Nashville
Oct 2026
New location: Los Angeles
Oct 2026
Added CDISC to stack
Oct 2026
Added GLP to stack
Oct 2026
Added GraphPad Prism to stack
Oct 2026
Added Medidata Rave to stack
Oct 2026
Added Veeva to stack
Oct 2026
Added CAPA to stack
Oct 2026
Added 21 CFR Part 11 to stack
Oct 2026
Added Good Clinical Practice to stack
Oct 2026
Added ICH Guidelines to stack
Oct 2026
Tech stack
Technologies named in job postings at Corcept Therapeutics over the last 12 months, by layer, with the share of postings for each.
Technologies in use
32
Postings analysed
28
Stack modernity
65/100
Languages
SAS14%
Python4%
SQL4%
Cloud & platforms
GCP29%
AWS11%
Tableau11%
Crowdstrike4%
Sign in to see how your skills match this stack
Sign In
Full Corcept Therapeutics tech stack
32 technologies · by team · pay by technology · changes · similar stacks
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Longitude CapitalVia a fund
78 portfolio companies: Zenas BioPharma, Mobia Medical, Inc. and 76 more
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Corcept's Lifyorli Gets Positive EU Opinion For Platinum-Resistant Ovarian Cancer
Corcept Therapeutics (CORT) said the EMA's CHMP recommended EU approval of Lifyorli (relacorilant) with nab-paclitaxel for platinum-resistant ovarian cancer. The recommendation was supported by Phase 3 ROSELLA data showing improved progression-free and ov
Read more
Report
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli (Relacorilant)
REDWOOD CITY, Calif., September 18, 2026--Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by
Read more
Report
Corcept Therapeutics Incorporated Receives CHMP Recommendation For EU Marketing Authorization For Lifyorli (Relacorilant) Combined With Nab-Paclitaxel For Platinum-Resistant ...
Read more
Report
Prevalence of Hypercortisolism in Individuals With Resistant Hypertension and Cardiovascular Disease
Presented: American Society for Preventive Cardiology (ASPC) 2026 Congress on CVD Prevention, 31 July 2026, Scottsdale, AZ Presenter: Pam R. Taub, MD Scientific journal publications or scientific congress presentations may include information regarding in
Read more
Report
Corcept Therapeutics Raises 2026 Revenue Outlook on Momentum
Detailed price information for Corcept Therapeutics (CORT-Q) from The Globe and Mail including charting and trades.
Read more
Report
Prevalence of Endogenous Hypercortisolism in Individuals With Resistant Hypertension Stratified by Kidney Function: Results From the MOMENTUM Study
Presented: 10th Annual Heart in Diabetes CME Conference, 19 June 2026, Philadelphia, PA Presenter: Ralph A. DeFronzo, MD Scientific journal publications or scientific congress presentations may include information regarding investigational products or use
Read more
Report
Efficacy and Safety of Relacorilant + Nab-paclitaxel in Patients Aged 65 Years With Platinum-resistant Ovarian Cancer (PROC) in the Phase 3 ROSELLA Study (GOG-3073, ENGOT-OV72, APGOT-Ov10)
Presented: European Society for Medical Oncology Gynaecological Cancers Annual Congress, 18 June 2026, Copenhagen, DK Presenter: Domenica Lorusso, MD, PhD Scientific journal publications or scientific congress presentations may include information regardi
Read more
Report
Real-World Comparative Effectiveness of Nab-paclitaxel and Standard of Care Chemotherapies in Patients With Platinum-Resistant Ovarian Cancer (COMPASS 2.0)
Presented: European Society for Medical Oncology Gynaecological Cancers Annual Congress, 18 June 2026, Copenhagen, DK Presenter: Mark S. Shahin, MD, FACOG, FACS Scientific journal publications or scientific congress presentations may include information r
Read more
Report
Endogenous Hypercortisolism in Individuals With Resistant Hypertension and Difficult-to-Control Type 2 Diabetes: Results From Two Large, Prospective Studies
Presented: Endocrine Society (ENDO) Annual Meeting, 15 June 2026, Chicago, IL Presenter: Ralph DeFronzo, MD Scientific journal publications or scientific congress presentations may include information regarding investigational products or uses. Download P
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
12
Hiring now
10
Countries
4
Busiest office
Redwood City
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Redwood City
United States
HQ
39 open roles 39 posted in 90 days 38% engineering 5% remote 200-500 est. staff $242k Avg Salary
hires for Biotech, Hardware, Finance
Washington
United States
Sales office
Field
11 open roles 14 posted in 90 days 9% engineering 36% remote 50-200 est. staff $177k Avg Salary
hires for Sales, Biotech, Hardware
Munich
Germany
Sales office
Germany
2 open roles 1 posted in 90 days 100% engineering 10-50 est. staff
hires for Hardware, Analytics
New York
United States
Sales office
Field
1 open roles 1-10 est. staff $155k Avg Salary
hires for Sales
Hartford
United States
1 open roles 1 posted in 90 days 1-10 est. staff $155k Avg Salary
hires for Sales
Birmingham
United States
1 open roles 1 posted in 90 days 1-10 est. staff $155k Avg Salary
hires for Sales
Montgomery
United States
1 open roles 1 posted in 90 days 1-10 est. staff $155k Avg Salary
hires for Sales
Pittsburgh
United States
1 open roles 1 posted in 90 days 1-10 est. staff $155k Avg Salary
hires for Sales
Los Angeles
United States
Field
1 open roles 1 posted in 90 days 100% remote 1-10 est. staff $220k Avg Salary
hires for Biotech
Scottsdale
United States
1 open roles 1-10 est. staff $155k Avg Salary
hires for Sales
Amsterdam
Netherlands
Regional office
Netherlands
1-10 est. staff
London
United Kingdom
Regional office
Europe
Earlier presence
Berlin, Germany
Seattle, United States
Louisville, United States
Fresno, United States
Bloomington, United States
Jacksonville, United States